A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02
Clinical trial NCT00583362 · COMPLETED
Trial details
- NCT number
- NCT00583362
- Sponsor
- Human Genome Sciences Inc., a GSK Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-04
- Primary completion
- 2016-02-23
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.